Skip to content
  • Submit

  • Category

  • Sort by

  • Per page

Found 9758 publications. Showing page 249 of 391:

Publication  
Year  
Category

Factors of change: using trophic magnification factors (TMFs) to assess changes in POP bioaccumulation in Arctic food webs. NILU F

Warner, N.A.; Hallanger, I.G.; Ruus, A.; Evenset, A.; Herzke, D.; Gabrielsen, G.W.; Borgå, K.

2011

Factors affecting bioaccumulation of cyclic volatile methyl siloxanes in a subarctic benthopelagic food web.

Krogseth, I. S.; Undeman, E.; Evenset, A.; Christensen, G. N.; Whelan, M. J.; Breivik, K.; Evenset, A.; Warner, N. A.

2017

Factors affecting bioaccumulation of cyclic volatile methyl siloxanes in a subarctic benthopelagic food web.

Krogseth, I. S.; Undeman, E.; Evenset, A.; Christensen, G. N.; Whelan, M. J.; Breivik, K.; Evenset, A.; Warner, N. A.

2017

Facilitating knowledge transfer: decision support tools in environment and health.

Liu, H.-Y.; Bartonova, A.; Neofytou, P.; Yang, A.; Kobernus, M.J.; Negrenti, E.; Housiadas, C.

2012

Extreme climate of the global troposphere and stratosphere in the 1940-42 related to El Nino.

Brönnimann, S.; Luterbacher, J.; Staehelin, J.; Svendby, T. M.; Hansen, G.; Svenøe, T.

2004

Extraordinary halocarbon emissions initiated by the 2011 Tohoku earthquake.

Saito, T.; Fang, X.; Stohl, A.; Yokouchi, Y.; Zeng, J.; Fukuyama, Y.; Mukai, H.

2015

Extracellular Vesicles as Next-Generation Diagnostics and Advanced Therapy Medicinal Products

Stawarska, Agnieszka; Bamburowicz-Klimkows, Magdalena; Rundén-Pran, Elise; Dusinska, Maria; Cimpan, Mihaela Roxana; Rios Mondragon, Ivan; Grudzinski, Ireneusz P.

Extracellular vesicles (EVs) hold great promise for clinical application as new diagnostic and therapeutic modalities. This paper describes major GMP-based upstream and downstream manufacturing processes for EV large-scale production, also focusing on post-processing technologies such as surface bioengineering and uploading studies to yield novel EV-based diagnostics and advanced therapy medicinal products. This paper also focuses on the quality, safety, and efficacy issues of the bioengineered EV drug candidates before first-in-human studies. Because clinical trials involving extracellular vesicles are on the global rise, this paper encompasses different clinical studies registered on clinical-trial register platforms, with varying levels of advancement, highlighting the growing interest in EV-related clinical programs. Navigating the regulatory affairs of EVs poses real challenges, and obtaining marketing authorization for EV-based medicines remains complex due to the lack of specific regulatory guidelines for such novel products. This paper discusses the state-of-the-art regulatory knowledge to date on EV-based diagnostics and medicinal products, highlighting further research and global regulatory needs for the safe and reliable implementation of bioengineered EVs as diagnostic and therapeutic tools in clinical settings. Post-marketing pharmacovigilance for EV-based medicinal products is also presented, mainly addressing such topics as risk assessment and risk management.

MDPI

2024

Extensive release of methane from Arctic seabed west of Svalbard during summer 2014 does not influence the atmosphere.

Myhre, C.L.; Ferré, B.; Platt, S.M.; Silyakova, A.; Hermansen, O.; Allen, G.; Pisso, I.; Schmidbauer, N.; Stohl, A.; Pitt, J.; Jansson, P.; Greinert, J.; Percival, C.; Fjaeraa, A.M.; O'Shea, S.J.; Gallagher, M.; Le Breton, M.; Bower, K.N.; Bauguitte, S.J.B.; Dalsøren, S.; Vadakkepuliyambatta, S.; Fisher, R.E.; Nisbet, E.G.; Lowry, D.; Myhre, G.; Pyle, J.A.; Cain, M.; Mienert, J.

2016

Publication
Year
Category